- NTLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Intellia Therapeutics (NTLA) S-3ASRAutomatic shelf registration
Filed: 12 Oct 18, 5:29pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement onForm S-3 of our report dated March 14, 2018, relating to the financial statements of Intellia Therapeutics, Inc., appearing in the Annual Report onForm 10-K of Intellia Therapeutics, Inc. for the year ended December 31, 2017, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.
/s/ Deloitte & Touche LLP |
Boston, Massachusetts |
October 12, 2018 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.